On Friday, Milestone Pharmaceuticals Inc (NASDAQ: MIST) was -6.85% drop from the session before settling in for the closing price of $2.19. A 52-week range for MIST has been $0.63 – $3.06.
A company in the Healthcare sector has jumped its sales by 28.21% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -6.80%. With a float of $81.04 million, this company’s outstanding shares have now reached $85.17 million.
Milestone Pharmaceuticals Inc (MIST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Milestone Pharmaceuticals Inc stocks. The insider ownership of Milestone Pharmaceuticals Inc is 4.85%, while institutional ownership is 41.01%. The most recent insider transaction that took place on Jan 08 ’26, was worth 96,750. In this transaction President and CEO of this company sold 43,000 shares at a rate of $2.25, taking the stock ownership to the 303,721 shares. Before that another transaction happened on Jan 07 ’26, when Company’s President and CEO sold 500 for $2.25, making the entire transaction worth $1,125. This insider now owns 346,721 shares in total.
Milestone Pharmaceuticals Inc (MIST) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.19 earnings per share (EPS) during the time that was less than consensus figure (set at -0.15) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.42% during the next five years compared to 28.21% growth over the previous five years of trading.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Trading Performance Indicators
You can see what Milestone Pharmaceuticals Inc (MIST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.51 in one year’s time.
